Skip to main content
OpenTrials
Completed

NCT Number: NCT02032472

Efficiency of Monitoring and Control Program of Hypertension Through Pharmacy Offices. APOF Project

Background: Hypertension in adults is the factor most prevalent cardiovascular risk and motivates further inquiries, generating a very high cost of medical care.

Objective: To evaluate the monitoring of well-controlled hypertensive patients Pharmacy Offices. Hypothesis: the monitoring of these patients through the Office of Pharmacy will be as effective in obtaining good control of blood pressure as it is to obtained through health centers. Design: Multicenter randomized controlled trial along one year of follow up. Location: the city of Cerdanyola del Vallès (Barcelona). Participants: All patients diagnosed with hypertension and good control criteria in the past year. Arms: Health centers (control) and Pharmacy Offices (intervention). Outcome variable: blood pressure under good control along the monitoring

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Institut Català de la Salut (ICS)

Cerdanyola Del Valllés, Barcelona, 08290, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age not less than 18 years
  • HTA controlled over 2 years of evolution
  • Subjects with a history open to participating health centers or stable residence in the geographic area
  • Subjects who agree to participate

Exclusion criteria

  • Comorbidity and concomitant (Diabetes Mellitus, Heart failure or renal failure
  • Patients with temporary residence in the geographic area of study
  • Subjects of hypertension controlled by outside professionals to our primary care teams.
  • Subjects with home care or any other cause which does not permit their displacement, transfer to the clinic or pharmacy during the evaluation period.
  • Subjects with severe diseases of poor prognosis, hopefully less than one year of life.
  • Subjects who do not have telephones.
  • Subjects with communication problems (cognitive impairment, sensory, language barrier)

Treatment and study plan

Measurement of Arterial Pressure

Other

Pharmacies cooperate in measuring blood pressure of patients

Primary outcomes

  1. Percentage of hypertensive patients with criteria for good control of their arterial pressure along one year follow up

    Time frame: Monitoring of patients for 12 months (from January 1 to December 31, 2010)

    We considered as a for good control criterion , obtaining values of systolic arterial pressure to below 140 mm Hg and diastolic blood pressure below 90 mm Hg dea, held along the entire the year follow-up of patients

Secondary outcomes

  1. reduction in the number of visits to the health center to measure blood pressure

    Time frame: Monitoring of patients for 12 months (from January 1 to December 31, 2010)

    The number of visits to the health center where blood pressure is measured. We hope that the number of visits to the health center where blood pressure is measured is lower in the intervention group (the patients have the option to go to the pharmacy to carrying out checks blood pressure)

Sponsors and collaborators

Lead sponsor

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

Other

Collaborators

  • Institut Catala de Salut

Registry information

Official study title

Efficiency Program Monitoring and Control of Hypertension Through Pharmacy Offices. APOF Project

Acronym: APOF

Important dates

Study start
2010
Primary completion
2011
Study completion
2012
First posted
Jan 10, 2014
Registry last updated
Jan 10, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.